New trial: could lymph node removal boost survival in kidney cancer?

NCT ID NCT07321210

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This trial is testing whether adding a template lymph node dissection (removing nearby lymph nodes) to the standard surgery for high-risk upper tract urothelial cancer helps patients live longer without the cancer returning. About 150 participants will be randomly assigned to get either standard surgery alone or standard surgery plus lymph node removal. They will be followed for up to 10 years to monitor for recurrence and complications.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Template Lymph Node Dissection (a surgical procedure to remove lymph nodes during kidney cancer surgery)
What this could lead to
If it works, this could show that removing lymph nodes during surgery helps prevent kidney cancer from coming back and improves survival.
What could go wrong
This is a relatively small, early-stage trial (150 people). Adding lymph node removal may increase surgery risks or complications without clear benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPH NODE DISSECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Tianjin Medical University Second Hospital

    RECRUITING

    Tianjin, Tianjin Municipality, 300211, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.